Degradation of plectin with modulation of cytokeratin 18 in human liver cells during staurosporine-induced apoptosis

In Vivo

Volumn 22, Issue 5, 2008, Pages 543-548

  Liu, Yi Hsiang ^a,b,c   Cheng, Chiung Chi ^c   Ho, Chin Chin ^d   Chao, Wei Ting ^e   Pei, Ren Jeng ^a,c   Hsu, Yung Hsiang ^b   Yeh, Kun Tu ^f   Ho, Lu Chang ^c   Tsai, Ming Chuang ^c   Lai, Yih Shyong ^c  

^a JEN AI HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Cytokeratin; Hepatocellular carcinoma; Plectin; Staurosporine

Indexed keywords

CYTOKERATIN 18; PLECTIN; STAUROSPORINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMEDIATE FILAMENT; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 53849147613     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Moll R, Franke WW, Schiller DL, Geiger B and Krepler R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24, 1982.
2. Van Eyken P and Desmet VJ: Cytokeratins and the liver. Liver 13: 113-122, 1993.
3. Loranger A, Duclos S, Grenier A, Price J, Wilson-Heiner M, Baribault H and Marceau N: Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am J Pathol 151: 1673-1683, 1997.
4. Omary MB and Ku NO: Intermediate filament proteins of the liver: emerging disease association and functions. Hepatology 25: 1043-1048, 1997.
5. Galarneau L, Loranger A, Gilbert S and Marceau N: Keratins modulate hepatic cell adhesion, size and G1/S transition. Exp Cell Res 313: 179-194, 2007.
6. Herrmann H and Aebi U: Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynanmics. Curr Opin Cell Biol 12: 79-90, 2000.
7. Green KJ, Bohringer M, Gocken T and Jones JC: Intermediate filament associated proteins. Adv Protein Chem 70:143-202, 2005.
8. Kazerounian S, Uitto J and Aho S: Unique role for the periplakin tail in intermediate filament association: specific binding to keratin 8 and vimentin. Exp Dermatol 11: 428-438, 2002.
9. Rezniczek GA, Janda L and Wiche G: Plectin. Methods Cell Biol 78: 721-755, 2004.
10. Svitkina TM, Verkhovsky AB and Borisy GG: Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J Cell Biol 135: 991-1007, 1996.
11. Steinbock FA, Nikolic B, Coulombe PA, Fuchs E, Traub P and Wiche G: Dose-dependent linkage, assembly inhibition and disassembly of vimentin and cytokeratin 5/14 filaments through plectin's intermediate filament-binding domain. J Cell Sci 113 (Pt 3): 483-491, 2000.
12. Schroder R, Kunz WS, Rouan F, Pfendner E, Tolksdorf K, Kappes-Horn K, Altenschmidt-Mehring M, Knoblich R, van der Ven PF, Reimann J, Furst DO, Blumcke I, Vielhaber S, Zillikens D, Eming S, Klockgether T, Uitto J, Wiche G and Rolfs A: Disorganization of the desmin cytoskeleton and mitochondrial dysfunction in plectin-related epidermolysis bullosa simplex with muscular dystrophy. J Neuropathol Exp Neurol 61: 520-530, 2002.
13. McLean WH, Pulkkinen L, Smith FJ, Rugg EL, Lane EB, Bullrich F, Burgeson RE, Amano S, Hudson DL, Owaribe K, McGrath JA, McMillan JR, Eady RA, Leigh LM, Christiano AM and Uitto J: Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev 10: 1724-1735, 1996.
14. Smith FJ, Eady RA, Leigh IM, McMillan JR, Rugg EL, Kelsell DP, Bryant SP, Spurr NK, Geddes JF, Kirtschig G, Milana G, de Bono AG, Owaribe K, Wiche G, Pulkkinen L, Uitto J, McLean WH and Lane EB: Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet 13: 450-457, 1996.
15. Nagle RB, Knox JD, Wolf C, Bowden GT and Cress AE: Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem Suppl 19: 232-237, 1994.
16. Su B, Pei RJ, Yeh KT, Hsu YH and Lai YS: Could the cytokeratin molecule be modulated during tumor transformation in hepatocellular carcinoma? Pathobiology 62: 155-159, 1994.
17. Liu YH, Pei RJ, Yeh CC, Lee KY, Yeh KT, Hsu YH, Ho CC and Lai YS: The alteration of cytokeratin 18 molecule and its mRNA expression during tumor transformation in hepatoma. Res Commun Mol Pathol Pharmacol 96: 243-253, 1997.
18. Liu YH, Su B, Pei RJ, Yeh CC, Yeh KT, Lee KY, Hsu YH, Ho CC and Lai YS: The stability of cytokeratin 18 in human liver cells during colchicine-induced microtubule disruption. Food Chem Toxicol 39: 85-89, 2001.
19. Liu YH, Ho CC, Cheng CC, Hsu YH and Lai YS: Photoradiation could influence the cytoskeleton organization and inhibit the survival of human hepatoma cells in vitro. Lasers Med Sci 21: 42-48, 2006.
20. Cheng CC, Liu YH, Ho CC, Chao WT, Pei RJ, Hsu YH, Yeh KT, Ho LC, Tsai MC and Lai YS: The influence of plectin deficiency on stability of cytokeratin 18 in hepatocellular carcinoma. J Mol Histol 39(Pt 2): 209-216, 2008.
21. Schuchmann M and Galle PR: Apoptosis in liver disease. Eur J Gastroenterol Hepatol 13: 785-790, 2001.
22. Patel T, Steer CJ and Gores GJ: Apoptosis and the liver: a mechanism of disease, growth regulation, and carcinogenesis. Hepatology 30: 811-815, 1999.
23. Schutte B, Henfling M, Kolgen W, Bouman M, Meex S, Leers MP, Nap M, Bjorklund V, Bjorklund P, Bjorklund B, Lane EB, Omary MB, Jornvall H and Ramaekers FC: Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res 297: 11-26, 2004.
24. Stegh AH, Herrmann H, Lampel S, Weisenberger D, Andra K, Seper M, Wiche G, Krammer PH and Peter ME: Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol Cell Biol 20: 5665-5679, 2000.
25. Jordà EG, Verdaguer E, Jimenez A, Arriba SG, Allgaier C, Pallas M and Camins A: Evaluation of the neuronal apoptotic pathways involved in cytoskeletal disruption-induced apoptosis. Biochem Pharmacol 70: 470-480, 2005.
26. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
27. Reuner KH, Dunker P, van der Does A, Wiederhold M, Just I, Aktories K and Katz N: Regulation of actin synthesis in rat hepatocytes by cytoskeletal rearrangements. Eur J Cell Biol 69: 189-196, 1996.
28. Crowe DL, Milo GE and Shuler CF: Keratin 19 down-regulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 78: 1256-1263, 1999.
29. Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL and Asch BB: Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res 56: 4841-4845, 1996.
30. Dandachi N, Hauser-Kronberger C, More E, Wiesener B, Hacker GW, Dietze O and Wirl G: Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol 193: 181-189, 2001.
31. Chakraborty J and von Stein GA: Pleomorphism of human prostatic cancer cells (DU 145) in culture - the role of cytoskeleton. Exp Mol Pathol 44: 235-245, 1986.
32. Foisner R, Traub P and Wiche G: Protein kinase A- and protein kinase C-regulated interaction of plectin with lamin B and vimentin. Proc Natl Acad Sci USA 88: 3812-3816, 1991.
33. Larsen AK, Moller MT, Blankson H, Samari HR, Holden L and Seglen PO: Naringin-sensitive phosphorylation of plectin, a cytoskeletal cross-linking protein, in isolated rat hepatocytes. J Biol Chem 277: 34826-34835, 2002.
34. Muenchbach M, Dell'Ambrogio M and Gazzotti P: Proteolysis of liver plectin by mu-calpain. Biochem Biophys Res Commun 249: 304-306, 1998.
35. Osmanagic-Myers S, Gregor M, Walko G, Burgstaller G, Reipert S and Wiche G: Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J Cell Biol 174: 557-568, 2006.
36. Sonnenberg A and Liem RK: Plakins in development and disease. Exp Cell Res 313: 2189-2203, 2007.